Dr. Mohammad Ashraf , MD
Internal Medicine • Madera, CA
1260 E Almond Ave
Madera, CA 936376500
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
Dr. Mohammad Ashraf is listed in NPPES under Internal Medicine.
-
NPI assigned on July 24, 2006; this date does not establish years in practice.
-
Published CMS data list 4,364 Original Medicare Part B services in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Published rows only; this is not a quality measure.
-
Published Part B service records, 2024:
- 99214 — Established patient outpatient office visit: 2,126 service units.
- J2785 — Injection, regadenoson, 0.1 mg: 476 service units.
- 93306 — Ultrasound of heart with color-depicted blood flow, rate, direction and valve function: 256 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2023 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2024). CPT notice
See all 21 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 7,027 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Metoprolol Succinate — 550 prescription fills, including refills.
- Amlodipine Besylate — 417 prescription fills, including refills.
- Atorvastatin Calcium — 404 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See all 106 records in the table · Guide: How to read Medicare Part D prescriber data
-
More Medicare Part B services than 90% of clinicians listed under Internal Medicine in California (2024, 8,014 clinicians with data). Median for this group: 546. Middle half: 197 to 1,236.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 8,844.2 in 2020 to 4,364 in 2024.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2020–2024.
Practice Location & Contact Primary Location
1260 E Almond Ave
Madera, CA 936376500
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
CMS Doctors and Clinicians lists 2 distinct group names: Arya Medical Group Corp; Camarena Health. See the list
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
Listings do not confirm current availability, employment or a shared ownership network.
Medicare Profile & Education
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
1971
What Public CMS Data Show
Internal Medicine: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare patients
489 people with Original Medicare in 2024
It gives a sense of how many people with Medicare this clinician treated that year.
Source: CMS, Medicare Physician & Other Practitioners – by Provider, 2024.
Medicare-allowed amount
About $439,728 in 2024
The total amount Medicare approved for these services in 2024. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
Paid by Medicare
About $308,879 in 2024
The part of the Medicare-allowed amount that Medicare itself paid in 2024, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2024.
30-day fills
13,935 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$952,641 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2025
All general payments: $632.87 across 30 records.
By nature of payment
- Food and Beverage: $612.65 across 29 records.
- Education: $20.22 across 1 record.
Reporting-company totals (3 largest of 10)
- Bayer Healthcare Pharmaceuticals Inc.: $188.09 across 8 records.
- Pfizer Inc.: $120.72 across 8 records.
- Bristol Myers Squibb Company: $70.83 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2025 (published June 30, 2026).
Years since graduation
55 years (graduated 1971)
CMS Doctors and Clinicians data list 1971 as the year this clinician finished professional school.
It tells you roughly how long ago the clinician finished school.
What this does not show: Years since graduation
It is not the number of years in practice, and more years does not mean better care.
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026.
NPI first issued
2006
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
May accept Medicare assignment
CMS data show this clinician may accept Medicare assignment. Clinicians who do not always accept assignment can decide case by case.
Ask the office before your visit. If a clinician does not accept assignment for a service, they can charge up to 15% more than the Medicare-approved amount, and you may be asked to pay the full amount at the visit.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians, CMS release of October 2, 2026; Medicare.gov, “Does your provider accept Medicare as full payment?”
Telehealth (some services)
Recent Medicare claims show this clinician provided some services by telehealth, such as a video or phone visit.
You may be able to have some visits without going to the office. Ask which visits can be done by telehealth.
What this does not show: Telehealth (some services)
It does not mean all services are offered by telehealth, or that telehealth is covered by your plan.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians, CMS release of October 2, 2026.
Enrolled in Medicare (PECOS)
Dr. Ashraf has a Medicare enrollment record in PECOS, the CMS system clinicians use to enroll so they can bill Medicare or order services for people with Medicare.
It does not show whether the clinician accepts assignment, is in your plan's network, or is taking new patients.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Can order Medicare-covered services
CMS lists Dr. Ashraf as eligible to order or refer Medicare Part B clinical laboratory and imaging services, durable medical equipment (DME) and home health services for people with Medicare.
Medicare pays for these items and services only when they are ordered by an eligible clinician.
What this does not show: Can order Medicare-covered services
It does not mean the clinician offers these services directly.
Source: CMS Medicare Fee-For-Service Public Provider Enrollment (PECOS); CMS Order and Referring file.
Compared with the same specialty in Madera and California
Billing and prescribing volume is not a quality rating.
Medicare Part B services
More Medicare Part B services than 90% of clinicians listed under Internal Medicine in California (2024, 8,014 clinicians with data). Median for this group: 546. Middle half: 197 to 1,236.
Too few clinicians listed under Internal Medicine in Madera have Medicare Part B data for 2024 to compare.
Medicare-allowed amount
A higher Medicare-allowed amount than 95% of clinicians listed under Internal Medicine in California (2024, 8,014 clinicians with data). Median for this group: $57,258. Middle half: $20,378 to $125,504.
Too few clinicians listed under Internal Medicine in Madera have Medicare Part B data for 2024 to compare.
Paid by Medicare
A higher Medicare payment amount than 90% of clinicians listed under Internal Medicine in California (2024, 8,014 clinicians with data). Median for this group: $43,360. Middle half: $14,871 to $95,733.
Too few clinicians listed under Internal Medicine in Madera have Medicare Part B data for 2024 to compare.
Medicare Part D prescriptions
More Part D prescriptions than 85% of clinicians listed under Internal Medicine in California (2024, 10,856 clinicians with data). Median for this group: 1,234. Middle half: 145 to 4,216.
Too few clinicians listed under Internal Medicine in Madera have Medicare Part D data for 2024 to compare.
Part D drug cost
A higher Part D drug cost than 90% of clinicians listed under Internal Medicine in California (2024, 10,856 clinicians with data). Median for this group: $86,595. Middle half: $7,293 to $305,458.
Too few clinicians listed under Internal Medicine in Madera have Medicare Part D data for 2024 to compare.
17 active clinicians are listed under Internal Medicine with a practice address in Madera, CA (17,897 in California).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Madera
17.6% of these 17 clinicians have the CMS telehealth indicator.
58.8% of these 17 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 51% from 8,844.2 in 2020 to 4,364 in 2024.
- 2020: 8,844.2
- 2021: 11,296
- 2022: 9,433
- 2023: 6,859
- 2024: 4,364
-
Medicare-allowed amount
Medicare-allowed amount stayed about the same: $471,341 in 2020 and $439,728 in 2024.
- 2020: $471,341
- 2021: $570,778
- 2022: $466,032
- 2023: $482,747
- 2024: $439,728
-
Paid by Medicare
Paid by Medicare decreased 10% from $342,546 in 2020 to $308,879 in 2024.
- 2020: $342,546
- 2021: $423,608
- 2022: $342,461
- 2023: $346,727
- 2024: $308,879
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 13% from 8,032 in 2020 to 7,027 in 2024.
- 2020: 8,032
- 2021: 7,483
- 2022: 6,959
- 2023: 6,833
- 2024: 7,027
-
30-day fills
30-day fills stayed about the same: 14,611 in 2020 and 13,935 in 2024.
- 2020: 14,611
- 2021: 14,127
- 2022: 13,642
- 2023: 13,760
- 2024: 13,935
-
Part D drug cost
Part D drug cost increased 40% from $681,554 in 2020 to $952,641 in 2024.
- 2020: $681,554
- 2021: $765,017
- 2022: $771,832
- 2023: $923,362
- 2024: $952,641
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $109.21 in 2021 to $632.87 in 2025.
- 2021: $109.21
- 2022: $321.41
- 2023: $1,476.08
- 2024: $677.91
- 2025: $632.87
Sources: CMS Medicare Physician & Other Practitioners (2024), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2025), CMS Doctors and Clinicians, CMS release of October 2, 2026, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2025 (payments made January 1 – December 31, 2025): 30 records totaling $632.87.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ABIOMED |
Food and Beverage
In-kind items and services
|
— | General | $30.00 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $28.99 |
| SCPHARMACEUTICALS INC. |
Food and Beverage
In-kind items and services
|
FUROSCIX | General | $28.94 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $28.31 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
CAMZYOS | General | $27.93 |
| Vifor Pharma, Inc. |
Food and Beverage
In-kind items and services
|
Veltassa | General | $27.21 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Adempas | General | $26.34 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Kerendia | General | $26.08 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Adempas | General | $25.22 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
VERQUVO | General | $25.13 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
CAMZYOS | General | $25.00 |
| ABIOMED |
Food and Beverage
In-kind items and services
|
— | General | $24.54 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
VERQUVO | General | $24.00 |
| Novo Nordisk Inc |
Food and Beverage
In-kind items and services
|
Ozempic | General | $23.93 |
| Bayer Healthcare Pharmaceuticals Inc. |
Food and Beverage
In-kind items and services
|
Adempas | General | $22.05 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $20.37 |
| Bayer Healthcare Pharmaceuticals Inc. |
Education
In-kind items and services
|
Kerendia | General | $20.22 |
| Merck Sharp & Dohme LLC |
Food and Beverage
In-kind items and services
|
VERQUVO | General | $19.37 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ELIQUIS | General | $18.71 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
ELIQUIS | General | $17.90 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ELIQUIS | General | $16.20 |
| Novartis Pharmaceuticals Corporation |
Food and Beverage
In-kind items and services
|
LEQVIO | General | $15.79 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ELIQUIS | General | $15.23 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ELIQUIS | General | $14.91 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
ELIQUIS | General | $14.07 |
(top 25 shown)
Source: CMS Open Payments, program year 2025, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2023 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2024; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
99214
Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more
|
2,126 | 430 | $175.00 | $117.85 |
|
J2785
Injection, regadenoson, 0.1 mg
|
476 | 118 | $75.00 | $7.25 |
|
93306
Ultrasound of heart with color-depicted blood flow, rate, direction and valve function
|
256 | 248 | $600.00 | $191.94 |
|
A9500
Technetium tc-99m sestamibi, diagnostic, per study dose
|
242 | 120 | $175.00 | $98.40 |
|
93000
Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report
|
196 | 158 | $62.00 | $13.63 |
|
93016
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician
|
123 | 122 | $50.00 | $19.38 |
|
93017
Exercise or drug-induced heart stress test with electrocardiogram (ecg)
|
123 | 122 | $150.00 | $28.09 |
|
93018
Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician
|
123 | 122 | $90.00 | $12.74 |
|
78452
Nuclear medicine studies of heart muscle at rest and with stress and spect
|
121 | 120 | $1000.00 | $426.71 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
107 | 74 | $125.00 | $82.30 |
|
90658
Influenza vaccine, trivalent, 0.5 ml dosage
|
73 | 73 | $20.00 | $19.60 |
|
G0008
Administration of influenza virus vaccine
|
73 | 73 | $35.00 | $32.91 |
|
99215
Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more
|
70 | 66 | $215.00 | $170.30 |
|
93922
Ultrasound study of arm and leg arteries
|
63 | 62 | $150.00 | $81.10 |
|
99205
New patient office or other outpatient visit with a high level of medical decision making, if using time, 60 minutes or more
|
45 | 45 | $275.00 | $208.03 |
|
83036
Hemoglobin a1c level
|
36 | 26 | $30.00 | $9.52 |
|
93325
Ultrasound of heart with color-depicted blood flow, rate and valve function
|
26 | 26 | $200.00 | $23.13 |
|
93351
Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report
|
26 | 26 | $750.00 | $226.52 |
|
99211
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional
|
23 | 16 | $30.00 | $22.78 |
|
93880
Ultrasound of both sides of head and neck blood flow
|
19 | 19 | $400.00 | $186.99 |
|
93224
Electrocardiogram (ecg) 2-day continuous with review and report by health care professional
|
17 | 16 | $275.00 | $66.36 |
Source: CMS Part B by Provider and Service, 2024; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Metoprolol Succinate | Metoprolol Succinate | 550 | 38,800 | $8,538.93 | 157 |
| Amlodipine Besylate | Amlodipine Besylate | 417 | 27,342 | $2,317.15 | 114 |
| Atorvastatin Calcium | Atorvastatin Calcium | 404 | 30,034 | $2,704.62 | 119 |
| Entresto | Sacubitril/Valsartan | 304 | 12,195 | $257,063.21 | 56 |
| Carvedilol | Carvedilol | 248 | 16,316 | $1,534.77 | 62 |
| Eliquis | Apixaban | 237 | 9,375 | $175,849.00 | 46 |
| Furosemide | Furosemide | 193 | 12,143 | $1,029.78 | 55 |
| Olmesartan-Hydrochlorothiazide | Olmesartan/Hydrochlorothiazide | 185 | 10,946 | $7,301.46 | 53 |
| Spironolactone | Spironolactone | 165 | 10,278 | $1,465.08 | 38 |
| Clopidogrel | Clopidogrel Bisulfate | 159 | 11,610 | $2,208.33 | 48 |
| Jardiance | Empagliflozin | 158 | 7,408 | $138,930.97 | 33 |
| Potassium Chloride | Potassium Chloride | 156 | 8,695 | $3,290.66 | 37 |
| Rosuvastatin Calcium | Rosuvastatin Calcium | 154 | 10,035 | $3,197.55 | 43 |
| Levothyroxine Sodium | Levothyroxine Sodium | 152 | 11,188 | $1,886.60 | 37 |
| Pantoprazole Sodium | Pantoprazole Sodium | 147 | 9,270 | $1,645.26 | 45 |
| Metformin Hcl | Metformin Hcl | 146 | 10,283 | $1,051.00 | 41 |
| Lisinopril | Lisinopril | 130 | 8,730 | $659.93 | 37 |
| Amiodarone Hcl | Amiodarone Hcl | 115 | 6,900 | $2,728.94 | 31 |
| Olmesartan Medoxomil | Olmesartan Medoxomil | 105 | 6,780 | $2,313.76 | 31 |
| Xarelto | Rivaroxaban | 102 | 4,580 | $87,661.53 | 25 |
| Celecoxib | Celecoxib | 101 | 4,394 | $4,533.72 | 27 |
| Nitroglycerin | Nitroglycerin | 97 | 2,954 | $1,354.96 | 54 |
| Meloxicam | Meloxicam | 86 | 3,270 | $287.44 | 16 |
| Montelukast Sodium | Montelukast Sodium | 82 | 5,030 | $1,124.37 | 18 |
| Gabapentin | Gabapentin | 81 | 3,450 | $707.15 | 18 |
(top 25 shown)
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
NUCC Taxonomy Code: 207R00000X
A physician who provides long-term, comprehensive care in the office and the hospital, managing both common and complex illness of adolescents, adults and the elderly. Internists are trained in the diagnosis and treatment of cancer, infections and diseases affecting the heart, blood, kidneys, joints and digestive, respiratory and vascular systems. They are also trained in the essentials of primary care internal medicine, which incorporates an understanding of disease prevention, wellness, substance abuse, mental health and effective treatment of common problems of the eyes, ears, skin, nervous system and reproductive organs.
NUCC Taxonomy Code: 207RC0000X
An internist who specializes in diseases of the heart and blood vessels and manages complex cardiac conditions such as heart attacks and life-threatening, abnormal heartbeat rhythms.
Medicare (PECOS) Enrollment & Ordering Eligibility
Source: CMS PECOSPRACTITIONER - INTERNAL MEDICINE
I20080124000276
CA
2860574282
Sources: CMS Provider Enrollment and Order and Referring. Medicare enrollment is a billing status, not an accreditation or quality rating.
Medicare Group Practice Enrollments
Source: CMS Doctors and Clinicians National Downloadable File, CMS release of October 2, 2026
Arya Medical Group Corp
121 Belmont Ave, Mendota, CA 936408231
Phone: 5594240610
Camarena Health
344 E 6th St, Madera, CA 936383631
Phone: 5596644000
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Internal Medicine - Rheumatology
Doctor of Medicine (M.D.)
Career & Practice History
NPI enumerated July 24, 2006.
No changes to the name, practice address, taxonomy or NPI status in this record have been observed in the monthly NPPES data files from January 2017 to November 2026.
NPI Administrative Meta
Other Internal Medicine Providers in Madera
- Dr. Kulraj Grewal, MD
- Dr. Steven Gustaveson, MD
- Dr. Tahir Hassan, MD
- Dr. Zafar Sheikh, MD
- Dr. Satwant Samrao, MD
- Dr. Pushkal Jadaun, MD
Mailing Address
1260 E Almond Ave
Madera, CA 936376500
Phone: 5596732259